Acetohydroxamic acid Pregnancy and Breastfeeding Warnings
Brand names: Lithostat
Medically reviewed by Drugs.com. Last updated on Sep 2, 2024.
Acetohydroxamic acid Pregnancy Warnings
Use is contraindicated.
US FDA pregnancy category: Not assigned
Risk summary: No data are available on the use of this drug in pregnant women to inform a drug-related risk.
Comments:
-This drug can harm a developing fetus.
-If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus.
Animal studies have revealed evidence of teratogenicity (retarded and/or clubbed rear leg, exencephaly, and encephalocele). There are no controlled data in human pregnancy.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Acetohydroxamic acid Breastfeeding Warnings
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Lithostat (acetohydroxamic acid)." Mission Pharmacal Company
References for breastfeeding information
- (2001) "Product Information. Lithostat (acetohydroxamic acid)." Mission Pharmacal Company
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.